Can a community health worker program save lives in advanced HIV?
NCT ID NCT07720128
First seen Jul 22, 2026 · Last updated Jul 24, 2026 · Updated 2 times
Summary
This trial tests whether a package of support from a community health worker can help adults hospitalized with advanced HIV in Lusaka, Zambia, stay in care and survive longer. Participants are randomly assigned to receive the ARC intervention or standard care and are followed for up to one year after discharge. The study measures mortality, viral suppression, and retention in HIV care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- A multi-component support package delivered by a community health worker, including medical and psychosocial help for advanced HIV disease and hospitalization
- What this could lead to
- If effective, this approach could reduce deaths and improve viral suppression among people with advanced HIV who are hospitalized.
- What could go wrong
- This is a single-site trial in Lusaka, Zambia, so results may not apply elsewhere. The intervention is complex and resource-intensive, and its success depends on community health worker availability.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HIV DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Teaching Hospital
Lusaka, Zambia
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.